Surveillance of Wastewater Bodies from Bannu, Khyber Pakhtunkhwa, Pakistan for Poliovirus
Abstract
Abstract Views: 0
Poliomyelitis is a viral disease caused by the poliovirus (PV), globally. This virus is responsible for Acute Flaccid Paralysis (AFP) in children in Pakistan. Due to this virus, thousands of children are paralyzed. This virus is transmitted through wastewater in a congested population. The target group of polioviruses comprises the children with no vaccination history. Different factors are involved which create hurdles in the process of vaccination. Some of them are false beliefs, as well as the lack of security for the vaccination team in different areas of Pakistan, especially in the Khyber Pakhtunkhwa (KPK) region. KPK is one of the few remaining regions in the world with a high rate of PV outbreaks. In KPK, District Bannu is among the districts with the highest number of cases of PV.
Downloads
References
Russo GB, Goyal T, Tyler K, Thakur KT. Re‐Emergence of poliovirus in the United States: considerations and implications. Ann Neurol. 2022;92(5):725–728. https://doi.org/10.1002/ana.26504
Thompson KM, Kalkowska DA. Review of poliovirus modeling performed from 2000 to 2019 to support global polio eradication. Expert Rev Vacc. 2020;19(7):661–686. https://doi.org/10.1080/14760584.2020.1791093
Macklin GR, O’Reilly KM, Grassly NC, et al. Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccine. Science. 2020;368(6489):401–405.
https://doi.org/10.1126/science.aba1238
Tebbens RJD, Pallansch MA, Cochi SL, et al. Modeling poliovirus transmission in Pakistan and Afghanistan to inform vaccination strategies in undervaccinated subpopulations: modeling poliovirus transmission in Pakistan and Afghanistan. Risk Anal. 2018;38(8):1701–1717. https://doi.org /10.1111/risa.12962
Rahimi F, Abadi ATB. Poliomyelitis outbreaks caused by circulation of the vaccine-derived poliovirus. Int J Surg. 2022;105:e106893. https://doi.org/10. 1016/j.ijsu.2022.106893
Bahar MW, Nasta V, Fox H, et al. A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation. Commun Biol. 2022;5(1):e1293. https://doi.org/10. 1038/s42003-022-04252-5
Bianchi FP, Larocca AMV, Bozzi A, et al. Long-term persistence of poliovirus neutralizing antibodies in the era of polio elimination: An Italian retrospective cohort study. Vaccine. 2021;39(22):2989–2994. https://doi. org/10.1016/j.vaccine.2021.04.005
Crawt L, Atkinson E, Tedcastle A, et al. Differences in antigenic structure of inactivated polio vaccines made from sabin live-attenuated and wild-type poliovirus strains: impact on vaccine potency assays. J Infect Dis. 2019;221(4):544–552. https://doi. org/10.1093/infdis/jiz076
Neu U, Mainou BA. Virus interactions with bacteria: partners in the infectious dance. PLOS Pathog. 2020;16(2):e1008234. https://doi. org/10.1371/journal.ppat.1008234
Kalkowska DA, Badizadegan K, Thompson KM. Modeling scenarios for ending poliovirus transmission in Pakistan and Afghanistan. Risk Anal. 2023;43(4):660–676. https://doi. org/10.1111/risa.13983
Keohane C (Katy), Chimelli L, Ryan A. Poliovirus infection and post polio syndrome. In: Chrétien F, Wong KT, Sharer LR, Keohane C (Katy), Gray F, eds. Infections of the Central Nervous System. 1st ed. Wiley; 2020:195–204. https://doi.org/10.1002/9781119467748.ch21
Li Hi Shing S, Lope J, Chipika RH, Hardiman O, Bede P. Extra-motor manifestations in post-polio syndrome (PPS): fatigue, cognitive symptoms and radiological features. Neurol Sci. 2021;42(11):4569–4581. https://doi. org/10.1007/s10072-021-05130-4
Gelaw A, Pietsch C, Tigabu Z, Liebert UG. Genotyping of enteroviruses and human parechoviruses highlights their diversity in Northwest Ethiopia. J Med Virol. 2020;92(12):3007–3015. https://doi.org/10.1002/jmv.25765
Uwishema O, Eneh SC, El Jurdi E, et al. Poliovirus returns to the UK after nearly 40 years: current efforts and future recommendations. Postgrad Med J. 2022;98(1165):816–819. https://doi.org/10.1136/pmj-2022-142103
Tushabe P, Bwogi J, Eliku JP, et al. Environmental surveillance detects circulating vaccine-derived poliovirus type 2 that was undetected by acute flaccid paralysis surveillance in 2021 in Uganda. Arch Virol. 2023;168(5):e140. https://doi.org/10.1007/s00705-023-05759-w
Verma AA, Jimenez MP, Tangermann RH, Subramanian SV, Razak F. Insecurity, polio vaccination rates, and polio incidence in northwest Pakistan. Proc Natl Acad Sci. 2018;115(7):1593–1598. https://doi.org/10.1073/pnas.1711923115
Bandyopadhyay AS, Zipursky S. A novel tool to eradicate an ancient scourge: the novel oral polio vaccine type 2 story. Lanc Infec Diseases. 2023;23(2):e67–e71. https://doi.org/10.1016/S1473-3099(22)00582-5
Habibzadeh F, Chumakov K, Sajadi MM, et al. Use of oral polio vaccine and the incidence of COVID-19 in the world. PLOS ONE. 2022;17(3):e0265562. https://doi. org/10.1371/journal.pone.0265562
Modlin JF, Chumakov K. Sabin strain inactivated polio vaccine for the polio endgame. J Infec Dis. 2020;221(4):504–505. https://doi.org/ 10.1093/infdis/jiz077
Estivariz CF, Kovacs SD, Mach O. Review of use of inactivated poliovirus vaccine in campaigns to control type 2 circulating vaccine derived poliovirus (cVDPV) outbreaks. Vaccine. 2023;41:A113–A121. https://doi.org/ 10.1016/j.vaccine.2022.03.027
Wilkinson AL, Zaman K, Hoque M, et al. Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial. Lancet Infec Dis. 2023;23(9):1062–1071. https://doi.org/10.1016/S1473-3099(23)00139-1
Aly AH, Mohamed BA, Awasthi SK, Abdallah SAO, Amin AF. MATLAB simulation based study on poliovirus sensing through one-dimensional photonic crystal with defect. Sci Rep. 2023;13(1):e9422. https://doi.org/10.1038/s41598-023-35595-6
Campagnola G, Peersen O. Co-folding and RNA activation of poliovirus 3Cpro polyprotein precursors. J Biol Chem. 2023;299(11):e105258. https://doi.org/10.1016/j.jbc.2023.105258
Adeyemi OO, Sherry L, Ward JC, et al. Involvement of a nonstructural protein in poliovirus capsid assembly. J Virol. 2019;93(5):e01447-18. https://doi.org/10.1128/JVI.01447-18
Aylward B, Tangermann R. The global polio eradication initiative: Lessons learned and prospects for success. Vaccine. 2011;29:D80–D85. https://d oi.org/10.1016/j.vaccine.2011.10.005
Kennedy SB, Macklin GR, Mason Ross G, et al. Poliovirus antibodies following two rounds of campaigns with a type 2 novel oral poliovirus vaccine in Liberia: a clustered, population-based seroprevalence survey. Lanc Glob Health. 2023;11(6):e917–e923. https://doi. org/10.1016/S2214-109X(23)00116-X
Ivanova OE, Yarmolskaya MS, Eremeeva TP, et al. Environmental surveillance for poliovirus and other enteroviruses: long-term experience in Moscow, Russian federation, 2004–2017. Viruses. 2019;11(5):e424. https://doi.org/10.3390/v11050424
Mohiyuddin Z, Ali MH. A lingering threat of polio in Pakistan: A 2023 Update. Asia Pac J Public Health. 2023;35(8): 555–556. https://doi.org/ 10.1177/10105395231205732
Kabir M, Afzal MS. Epidemiology of polio virus infection in Pakistan and possible risk factors for its transmission. Asian Pac J Trop Med. 2016;9(11):1044–1047. https://doi. org/10.1016/j.apjtm.2016.09.006
O’Reilly KM, Verity R, Durry E, et al. Population sensitivity of acute flaccid paralysis and environmental surveillance for serotype 1 poliovirus in Pakistan: an observational study. BMC Infect Dis. 2018;18(1):e176. https://doi.org/10.1186/s12879-018-3070-4
Quarleri J. Poliomyelitis is a current challenge: long-term sequelae and circulating vaccine-derived poliovirus. GeroScience. 2023;45(2):707–717. https://doi.org/10.1007/s11357-022-00672-7
Weil M, Sofer D, Shulman LM, et al. Environmental surveillance detected type 3 vaccine-derived polioviruses in increasing frequency at multiple sites prior to detection of a poliomyelitis case. Sci Total Environ. 2023;871:e161985. https://doi.org/10. 1016/j.scitotenv.2023.161985
Jorgensen D, Pons-Salort M, Shaw AG, Grassly NC. The role of genetic sequencing and analysis in the polio eradication programme. Virus Evol. 2020;6(2):veaa040. https://doi.org/10. 1093/ve/veaa040
Zhou NA, Fagnant-Sperati CS, Komen E, et al. Feasibility of the bag-mediated filtration system for environmental surveillance of poliovirus in Kenya. Food Environ Virol. 2020;12(1):35–47. https://doi.org/10.1007/s12560-019-09412-1
Bigouette JP, Henderson E, Traoré MA, et al. Update on vaccine-derived poliovirus outbreaks — worldwide, January 2021–December 2022. MMWR Morb Mortal Wkly Rep. 2023;72(14):366–371. https://doi.org/ 10.15585/mmwr.mm7214a3
Molodecky NA, Jafari H, Safdar RM, et al. Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemic. Vaccine. 2023;41:A93–A104. https://d oi.org/10.1016/j.vaccine.2021.09.037
Manukyan H, Rodionova E, Zagorodnyaya T, Lin TL, Chumakov K, Laassri M. Multiplex PCR-based titration (MPBT) assay for determination of infectious titers of the three Sabin strains of live poliovirus vaccine. Virol J. 2019;16(1):e122. https://doi.org/10.1186/s12985-019-1233-6
Falman JC, Fagnant-Sperati CS, Kossik AL, Boyle DS, Meschke JS. Evaluation of secondary concentration methods for poliovirus detection in wastewater. Food Environ Virol. 2019;11(1):20–31. https://doi.org/10. 1007/s12560-018-09364-y
Sherwood AV, Rivera-Rangel LR, Ryberg LA, et al. Hepatitis C virus RNA is 5′-capped with flavin adenine dinucleotide. Nature. 2023;619(7971):811–818. https://doi. org/10.1038/s41586-023-06301-3
Joffret ML, Polston PM, Razafindratsimandresy R, Bessaud M, Heraud JM, Delpeyroux F. Whole genome sequencing of enteroviruses species A to D by high-throughput sequencing: application for viral mixtures. Front Microbiol. 2018;9:e2339. https://doi.org/10.3389 /fmicb.2018.02339
Snider CJ, Boualam L, Tallis G, et al. Concurrent outbreaks of circulating vaccine-derived poliovirus types 1 and 2 affecting the republic of the Philippines and Malaysia, 2019–2021. Vaccine. 2023;41:A58–A69. https://doi.org/10.1016/j.vaccine.2022.02.022
Mbani CJ, Nekoua MP, Moukassa D, Hober D. The fight against poliovirus is not over. Microorganisms. 2023;11(5):e1323. https://doi.org/10. 3390/microorganisms11051323
Tavares FN, Da Costa EV, Kew OM, Da Silva EE. Complete genome sequence of the last representative genotype of wild indigenous poliovirus type 1, which circulated in Brazil. Genome Announc. 2013;1(6):e00811-13. https://doi.org/10.1128/genomeA .00811-13
Owino CO, Chu JJH. Recent advances on the role of host factors during non-poliovirus enteroviral infections. J Biomed Sci. 2019;26(1):e47. https:// doi.org/10.1186/s12929-019-0540-y
Nandi SS, Gohil T, Sawant SA, Lambe UP, Ghosh S, Jana S. CD155: a key receptor playing diversified roles. Curr Molecul Med. 2022;22(7):594–607. https://doi.org/10.2174/1566524021666210910112906
Ali M, Ahmad N, Khan H, Ali S, Akbar F, Hussain Z. Polio vaccination controversy in Pakistan. Lancet. 2019;394(10202):915–916. https://doi. org/10.1016/S0140-6736(19)32101-4
Shulman LM, Gavrilin E, Jorba J, et al. Molecular epidemiology of silent introduction and sustained transmission of wild poliovirus type 1, Israel, 2013. Eurosurveillance. 2014;19(7):e20709. https://doi.org/10.2 807/1560-7917.ES2014.19.7.20709
Hsu CH, Wannemuehler KA, Soofi S, et al. Poliovirus immunity among children under five years-old in accessible areas of Afghanistan, 2013. Vaccine. 2019;37(12):1577–1583. https://doi.org/10.1016/j.vaccine.2019.02.008
Arita M, Iwai-Itamochi M. Evaluation of antigenic differences between wild and Sabin vaccine strains of poliovirus using the pseudovirus neutralization test. Sci Rep. 2019;9(1):e11970. https://doi.org/10.1038/s41598-019-48534-1
Copyright (c) 2023 Shabab Hussain, Nazish Bostan, Sabir Hussain, Samra Zahra, Amira Mahfoudhi
This work is licensed under a Creative Commons Attribution 4.0 International License.
BSR follows an open-access publishing policy and full text of all published articles is available free, immediately upon publication of an issue. The journal’s contents are published and distributed under the terms of the Creative Commons Attribution 4.0 International (CC-BY 4.0) license. Thus, the work submitted to the journal implies that it is original, unpublished work of the authors (neither published previously nor accepted/under consideration for publication elsewhere). On acceptance of a manuscript for publication, a corresponding author on the behalf of all co-authors of the manuscript will sign and submit a completed the Copyright and Author Consent Form.
